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a b s t r a c t
Background: Voltage mapping is critical to define substrate during ablation. In ventricular tachycardia,
abnormal potentials may be targets. However, wavefront of activation could impact local signal char-
acteristics. This may be particularly true when comparing sinus rhythm versus paced rhythms. We
sought to determine how activation wavefront impacts electrogram characteristics.
Methods: Patients with ischemic cardiomyopathy, ventricular tachycardia, and without fascicular or
bundle branch block were included. Point by point mapping was done and at each point, one was ob-
tained during an atrial paced rhythm and one during a right ventricular paced rhythm. Signals were
adjudicated after ablation to define late potentials, fractionated potentials, and quantify local voltage.
Areas of abnormal voltage (defined as <1.5 mV) were also determined.
Results: 9 patients were included (age 61.3 ± 9.2 years, 56% male, mean LVEF 34.9 ± 8.6%). LV endo-
cardium was mapped with an average 375 ± 53 points/rhythm. Late potentials were more frequent
during right ventricular pacing (51 ± 21 versus 32 ± 15, p < 0.01) while overall scar area was higher
during atrial pacing (22 ± 11% vs 13 ± 7%, p < 0.05). In 1/9 patients, abnormal potentials were seen during
a right ventricular paced rhythm that were not apparent in an atrial paced rhythm, ablation of which
resulted in non-inducibility.
Conclusion: Rhythm in which mapping is performed has an impact on electrogram characteristics.
Whether one rhythm is preferable to map in remains to be determined. However, it is possible defining
local signals during normal conduction as well as variable paced rhythms may impart a greater likelihood
of elucidating arrhythmogenic substrate.
Copyright © 2020, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Catheter ablation is a widely accepted therapy for ventricular
tachycardia (VT) refractory to drugs in structurally abnormal hearts
[1,2]. Entrainment and activation mapping have been considered
the gold standard to identify areas containing critical isthmuses for
the VTcircuit. However, in the presence of hemodynamic instability
and multiple or non-inducible VTs, substrate-based approaches
may be an acceptable alternative [3e5].
Substrate guided ablation involves targeting areas of local
abnormal ventricular activation (LAVA), i.e., late potentials and re-
gions of fragmented signals suggestive of local slowing of con-
duction, or targeting low voltage areas as traditionally defined by
pre-specified cutoff values. Previous reports suggest that target-
ing the scar region and/or complete elimination of LAVA is associ-
ated with improved VT free survival [3,6]. However, the anatomical
location of scar within ventricular myocardium has been previously
described to affect signal characteristics [7]. It is further known that
the direction of activation wavefront may alter the appearance of
local electrograms. These rhythm associated changes could include
the voltage amplitude (and thereby definition as scar versus border
zone versus normal tissue), and local signal properties (including
differentiation as a fractionated potential, late potential, or split
potential). Such changes could, in turn, impact identification of
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areas of interest for a substrate-based ablation strategy.
In this study, we sought to rigorously define how LAVA char-
acteristics, scar region and areas of abnormal voltage are affected
during an atrial paced rhythm, during which ventricular activation




This study enrolled 9 ischemic cardiomyopathy patients un-
dergoing VT ablation using a 3D electroanatomic mapping system.
All patients had recurrent sustained VT refractory to anti-
arrhythmic drugs resulting in implantable cardioverter defibril-
lator therapy. A written informed consent was obtained in all pa-
tients. The Mayo Clinic Institutional Board Review approved the
study.
2.2. Electrophysiological study
All anti-arrhythmic drugs were discontinued at least 5 half-lives
prior to the ablation if there was no sustained VT (one month in the
case of amiodarone). ICD therapies were turned off prior to the start
of the procedure. A 5 French (Fr.) quadripolar catheter was placed in
the right ventricular apex and a 7 Fr. decapolar catheter was placed
in the coronary sinus. The use of other diagnostic catheters was up
to the discretion of the provider. The left ventricular endocardium
was accessed either via retrograde aortic or transeptal approach.
Epicardial mapping or ablation was only performed if clinically
indicated during the study.
2.3. Electroanatomic mapping
Mapping was performed using a CARTO 3 (Biosense Webster,
Diamond Bar, CA) mapping system. A detailed point-to-point map
using an ablation catheter (THERMOCOOL® Biosense Webster) was
created. At each location, a point would be acquired during pacing
from an atrial catheter and a point would then be acquired during
right ventricular pacing at the same rate. All bipolar signals were
recorded between the distal electrode pair and filtered from 30 to
400 Hz and displayed at 100 mm/s.
Low voltage ventricular myocardium was defined as peak to
peak bipolar voltage of <1.5 mV and a voltage of <0.5 mV with
inability to capture at high output was defined as scar. Fractionated
signals were defined as sharp high frequency local signals of low
amplitude showing multiple components. Late signals were
defined as sharp high-frequency local ventricular signals of any
amplitude occurring after the onset of QRS, separated from the far-
field ventricular signal by an iso-electric segment.
A complete LV map was made in both rhythms and all points
were retrospectively reviewed and adjudicated by two indepen-
dent operators. Maps were set to a fill threshold of 10 mm.
2.4. Radiofrequency ablation
The ablation procedure was performed independent of the re-
sults of the study. Activation and entrainment mapping were used
to guide ablationwhere feasible. When a substrate-based approach
was used, the areas targeted for ablationwere at the sole discretion
of the physician. All patients underwent pre- and post-ablation
programmed ventricular stimulation using drive trains of 600 ms
and 400 ms with single, double, and triple extra stimuli from two
different sites.
2.5. Statistical analysis
All continuous variables are expressed as mean ± SD and were
compared using the student t-test. Categorical variables are
expressed as absolute number and percentages. All tests were two-
tailed with a p < 0.05 considered significant.
3. Results
3.1. Demographics
Baseline characteristics of the patients are described in detail in
Table-1. The average age was 61.3 ± 9.2 years with 56% male. The
mean LVEF was 34.9 ± 8.6% The LV endocardiumwas mapped with
an average of 375 ± 53 points/rhythm for each patient.
3.2. Effect of rhythm on electrogram characterization and bipolar
voltage
Of all the electrograms reviewed, late potentialswere noted to be
more frequent during RVpacing (Table 2). Therewas nonet effect on
number of fractionated potentials seen. Low voltage points were
more frequent during atrial pacing. Fig.1 shows an example of a late
Table 1

















VT induced at the beginning
of the case
VT inducible at the end
of the case
1 65 F No Yes Yes Yes 62 21 Anterior CABG No Yes No
2 69 M No No No No 65 40 Inferior/
Lateral
CABG No Yes No
3 68 M No No Yes No 65 37 Inferior PCI Yes Yes No
4 68 M No Yes No No 64 38 Inferior CABG/PCI No Yes No
5 51 F Yes Yes No Yes 73 35 Anterior PCI No Yes No
6 71 M Yes No Yes No 75 20 Inferior CABG No Yes No
7 61 F No Yes No No 59 45 Anterior PCI No Yes No
8 45 M Yes Yes No Yes 63 38 Inferior PCI No Yes Yes
9 54 F No Yes No No 65 40 Inferior PCI No Yes No
(Abbreviations; M ¼ Male; F ¼ female; DM ¼ Diabetes mellitus; HTN¼Hypertension; CKD¼Chronic Kidney Disease; LVEDD ¼ Left ventricular end-diastolic diameter;
LVEF ¼ Left ventricular ejection fraction; PCI¼Percutaneous Coronary Intervention; CABG¼Coronary Artery Bypass Grafting).
Table 2
Differences in substrate parameters based on the rhythm.
Right atrial pacing Right ventricular pacing P value
Late potentials 32 ± 15 51 ± 21 P < 0.01
Fractionated potentials 97 ± 44 103 ± 42 P¼NS
Low voltage sites 160 ± 90 121 ± 87 P < 0.05
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potential during atrial pacing that fuses during ventricular pacing.
Fig. 2 shows as example of change in the voltage distribution and
scar burdenwith change in rhythm in 1 patient. Table 3 summarizes
the frequencyof late versus fractionated potentials based on the scar
distribution in individual patients. There was no significant differ-
ence in the frequency of late potentials in septal scars during atrial
versus ventricularpacing (37±12versus50±20, p¼0.31) or innon-
septal scars (29± 17 versus 51± 24, p¼ 0.13). Similarly, therewas no
significant difference in the frequency of fractionated potentials in
septal scars (107±42versus110±39, p¼0.92) or innon-septal scars
(90 ± 49 versus 97 ± 49, p ¼ 0.83).
3.3. Outcomes
Amongst the9patients, 3 patientshad at least 1mappableVTand
all patients had at least 1 unmappable VT. Thus, substrate based
ablation and ablation targeted at pace mapping within the scar re-
gionwereperformed in all patients. Five of thepatientswereablated
based on substrate identified during an atrial paced rhythmand four
patients were ablated based on substrate identified during a right
ventricular paced rhythm.Programmedstimulationperformedafter
ablation demonstrated non-inducibility in 3/5 atrial paced patients
and 4/4 ventricular paced patients. In the 2/2 atrial paced patients
who were still inducible post ablation, review of the ventricular
pacedmap demonstrated a corresponding regionwhere therewere
apparent late potentials not apparent in the atrial paced map,
extending 2.5 mm beyond the margins where ablation had been
performed in the latter (Fig. 3). Pace-mapping here exhibited similar
morphology to the induced VTand further ablation resulted in non-
inducibility in 1 though 1 patientwas still inducible for a faster, non-
Fig. 1. Example of a change in potential during (a) atrial pacing (b) ventricular pacing. Note during atrial pacing there is a late potential that is fused during ventricular pacing to the
local EGM (yellow arrow).
D.K. Kella et al. / Indian Pacing and Electrophysiology Journal 20 (2020) 147e153 149
Downloaded for Anonymous User (n/a) at Washington University in Saint Louis Bernard Becker Medical Library from ClinicalKey.com by Elsevier on September 29, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
clinical VT that was not targeted. There were no adverse events
during the study or as part of the ablation. Over 1 ± 0.5 year follow-
up, there was no VT recurrence amongst 7 patients, 4 of whom
remainedonantiarrhythmicdrugs (1 amiodarone, 2 sotalol) and3of
whom discontinued antiarrhythmic drugs. The 2 patients with
recurrence underwent redo ablation at 6 months and 9 months,
respectively (1was inducible at the end of the procedure). Notably,1
of the patients had been ablated based on the atrial paced rhythm
and the other based on a ventricular paced rhythm.
Fig. 2. Change in voltage at specific points during atrial vs. ventricular pacing (a) RAO (b) LAO.
Table 3
Scar distribution and impact of activation path on late and fractionated potentials.
Patient Number Scar distribution Late potentials Fractionated
potentials
A-pace V-pace A-pace V-pace
1 Anterolateral 25 45 140 151
2 Inferior/inferolateral 43 75 113 116
3 Inferior 19 39 94 102
4 Inferior/inferoseptal 54 78 121 129
5 Septal 26 31 113 111
6 Inferior/inferolateral 49 76 94 99
7 Anteroseptal 31 45 145 143
8 Inferoseptal 37 45 47 55
9 Inferior/inferolateral 8 21 10 18
Fig. 3. Example of a case in which initial ablation was done on the atrial paced map. VT (middle left ECG) was still inducible. On the ventricular paced voltage map (right hand map)
there were areas of late potentials not obvious during atrial pacing (left hand map), pacing at which showed similarity to the inducible VT. Ablation here rendered the patient
subsequently non-inducible.
Fig. 4. Impact of wavefront directionality on electrogram. Shown is a schematic of
how orientation of the wavefront to a region of myocardial abnormality may impact
appearance of an electrogram. In the case of a wavefront that is perpendicular to an
area of substrate, in which the wave must propagate slowly through channels in the
substrate region, one may see a fractionated potential. If parallel, however, the elec-
trogram may appear singular without fractionation if velocity is similar on both sides.
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Fig. 5. Impact of normal His purkinje system conduction versus RV pacing on electrogram appearance in region of substrate. Demonstrated is one potential mechanism for
why electrograms may appear different depending on the wavefront of activation. In Fig. 5AeB, there are two wavefronts from fascicular activation with entry into the substrate
zone approaching the cathode from 2 angles e one through normal tissue and the other via the scar (5B). As a result, wavefronts all collide in the area of scar simultaneously
resulting in appearance of a single signal. In Fig. 5CeF, there is a singular wavefront during RV pacing which results in a single electrogram as it reaches the cathode (5D). Then it
slowly traverses the scar zone, eventually passing the bipolar recording electrode again resulting in a second (or late) potential.
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4. Discussion
The main findings of this study are that the vector of ventricular
depolarization alters the timing, amplitude, and quality of the
signal during mapping. Furthermore, in one patient, the appear-
ance of late potentials in RV pacing outside the scar area noted
during atrial pacing were a target for additional ablation, resulting
in non-inducibility. These findings support the critical importance
of wavefront in discriminating local signals during cardiac mapping
and ablation. Furthermore, as noted in Fig. 1, we demonstrate one
casewhere a late potential visible during native conductionwas not
obvious during right ventricular pacing. This stands within reason
as it can be assumed that a path of activation using trans-septal
activation of the left ventricle during right ventricular pacing may
similarly mask activation of certain potentials due to the activation
path through a region of scar. Specifically, relative differences in
path of activation and entrance into the scar zone during wavefront
propagation from two different sites may alter the potential for
unmasking signals suggestive of arrhythmogenicity. This principle
partly underlies the reasoning of using at least two sites for stim-
ulation during induction protocols in reentry based arrhythmias.
Furthermore, the distribution of scar may impact the relevant ef-
fects of activation wavefront, with a greater effect on manifestation
of late potentials with RV pacing for lateral scars than septal scars
though this did not bear out in subgroup analyses in our study
group.
Surviving myocardial cells in scar are a critical part of the VT
circuit [8]. Sinus or atrial paced rhythm conducts via the fast Pur-
kinje system and allowing synchronous activation of the LV in
healthy and diseased myocardium [9,10]. During RV apical pacing,
LV activation typically occurs trans-septally, though it is possible
that the native conduction system could be engaged as well. For
example, in some instances, part of the left ventricle during RV
pacing may get activated via retrograde activation of the right
bundle branch, thus resulting in different vectors of depolarization.
Further, the orientation of the electrical wavefront, parallel or
perpendicular, to the surviving myocardial cells may alter the
temporal spacing of the recorded signals [11] (Fig. 4). Thus a late
signal may become earlier in relation to the QRS complex
depending on the propagation wavefront (Fig. 5). This may be the
case in both cases of native conduction based ventricular activation
or ventricular pacing.
In our study, there was a significant increase in LAVA points
during RV pacing. This may be due to the lack of involvement of the
conduction system allowing for slow conduction and better tem-
poral resolution of the local signal. Moreover, this separation may
have an effect on the amplitude of the local signal, thus changing
the voltage in the area and alter the perceived “low voltage” po-
tentials as seen in our study. Intervening areas of functional and
anatomical block from scar may result in further change in the
activation wavefront as has been described previously [12]. The
lateness of LAVA has previously been shown to be dependent on the
location of the scar [7]. This distance will also differ based on the
direction of the wavefront as areas of early activation during sinus
rhythm may become late during RV pacing, thus affecting LAVA
characteristics and may be one of the reasons for the difference in
the presented data. It is possible that consistent appearance of
LAVA, irrespective of the rhythm, may be a more specific marker to
identify high yield areas to target during catheter ablation. How-
ever, these inferences based on this small study are speculative at
best and require more data. Furthermore, given our study was
focused on the same precise spot being obtained during both
pacing trains, many points were discarded for purposes of analysis
and thus extrapolation of scar area due to the high amount of
interpolation between a relatively smaller number of points
comprising the overall map could not be done reliably.
4.1. Limitations
This is a proof-of-concept study and is best interpreted in the
context of its limitations. This study did not account for disease
within the conduction system, which may vary from patient to
patient. We exclusively used the Carto mapping system for our
study and our findings may not apply to other mapping systems
due to differences in proprietary filters and algorithms. We did not
assess the impact of different pacing cycle lengths as it may also
alter local conduction velocity. Moreover, the clinical benefit in
terms of improved outcomes of VTablation of either approach is yet
to be determined. Further, we did point to point mapping in order
to ensure comparison during RV pacing and atrial pacing at each
point dependably. Thus, the limited number of points obtained may
limit extrapolation to cases of higher density mapping wherein less
interpolation is needed. Finally, given the small number of patients
considered, larger studies are required to determine consistency of
the findings and potential role in defining ablation strategies when
choosing the rhythm in which to map.
5. Conclusion
In conclusion, we here demonstrate that the rhythm at the time
of mapping has a significant impact on the definition of the
arrhythmic substrate of interest during ablation of VT. Future larger
studies evaluating the role of each technique in overall outcomes
(such as whether one rhythm is optimal over another) of the
ablation procedure are needed.
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